Steribite Raises $711.8K in Seed Funding for Sterile Surgical Instruments

Steribite, LLC, a privately held medical device company specializing in sterile, single-use and limited-use surgical instruments for spine and neurosurgery, has raised $711,800 in seed funding. The round was announced on September 2, 2026.

About Steribite

Steribite develops and manufactures surgical instruments designed to replace reusable tools that are difficult to clean, expensive to maintain, and carry infection risk. Their product line includes an FDA 510(k)-cleared disposable Kerrison rongeur and the SteriSharp limited-use line. The company aims to improve operating-room efficiency and patient safety.

Company Background

Steribite was spun out of Cleveland-based RJR Surgical and is led by CEO John A. Redmond. In 2021-2022, the company merged with contract manufacturer Precision Manufacturing Group, and now manufactures all products at its own facility in Wooster, Ohio.

Funding Details

• Round: Seed
• Amount: $711,800
• Announced: September 2, 2026

This seed funding will likely support Steribite's ongoing operations and expansion in the medical device market.